Limited activity: This researcher has not published recently (last publication: 2016). Profile data may be outdated.
Match tier Listed
Presence Current · Arkansas
Last published 2016
Sources OpenAlex · ORCID
Refreshed 2026-08-08

VK Todorova

Researcher

Unknown Researcher

1 h-index 4 pubs 15 cited

  • Protein Serine-Threonine Kinases
  • Adenocarcinoma
  • Administration, Oral
  • Animals
  • Breast Neoplasms
  • Carcinogens
  • Disease Models, Animal
  • Female
  • Glutamine
  • Glutathione
  • Insulin-Like Growth Factor I
  • Proto-Oncogene Proteins
  • 9,10-Dimethyl-1,2-benzanthracene
  • Signal Transduction
  • Biomarkers

Biography and Research Information

OverviewAI-generated summary

VK Todorova's research has focused on the study of drug metabolism and the potential adverse effects of various compounds, including pharmaceuticals and environmental agents. Their work has investigated the mechanisms by which the body processes these substances and the resulting toxicological outcomes. This includes examining interactions with cellular components and the development of biomarkers for exposure and effect.

Metrics

  • h-index: 1
  • Publications: 4
  • Citations: 15

Selected Publications

  • Abstract P1-15-02: Gene expression profiling of doxorubicin cardiotoxicity in peripheral blood cells of breast cancer patients (2016)
    Cancer Research DOI OpenAlex
  • P5-20-05: Peripheral Blood Transcriptomics and Doxorubicin Cardiotoxicity. (2011)
    Cancer Research DOI OpenAlex
  • Effect of glutamine on doxorubicin-induced cardiotoxicity: an echocardiographic assessment. (2009)
    Cancer Research DOI OpenAlex
  • Oral glutamine (AES‐14) supplementation inhibits PI‐3k/Akt signaling in experimental breast cancer (2003)
    Journal of Parenteral and Enteral Nutrition 15 citations DOI OpenAlex

View all publications on OpenAlex →

Similar Researchers

Based on overlapping research topics